Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Bierbeek – page 36

1 924 clinical trials in Bierbeek, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Bierbeek at a glance
1 924
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 924 trials in Bierbeek

Open in trial search

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tifcemalimab
  • Sponsor:Shanghai Junshi Biosciences Co. Ltd.

Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mexiletine
  • Sponsor:Lupin Atlantis Holdings S.A.

Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Ascentage Pharma Group Inc.

Study on Oxytocin and Mindfulness Training for Reducing Stress in Adults with Psychological Distress

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:UZ Leuven

Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis Hydrochloride
  • Sponsor:Eidos Therapeutics Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose-Derived Stem Cells
  • Sponsor:Novadip Biosciences

Study on Low-Dose Colchicine for Patients with Peripheral Artery Disease to Reduce Cardiovascular Risks

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Hamilton Health Sciences Corporation

Study on Neoadjuvant Chemotherapy and Immunotherapy with Ipilimumab, Pemetrexed, and Drug Combination for Patients with Inoperable Pleural Mesothelioma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Antwerp University Hospital

Study on the Effects of Ketorolac and Pregabalin in Patients Undergoing Surgery for Early Estrogen Receptor-Positive Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ketorolac
  • Sponsor:Institut Jules Bordet

Hidradenitis+2

Recruiting

Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rifampicin
  • Sponsor:UZ Leuven

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Bierbeek

What the registry says about research in the country

01 Mental Health Research

Ongoing clinical investigations focusing on schizophrenia and cognitive impairment, evaluating long-term safety profiles of innovative therapeutic approaches.

  • Cognitive Function Assessment
  • Treatment Safety Evaluation
  • Extended Care Studies

This research builds upon previous clinical trials, specifically examining the continued effectiveness and safety of iclepertin in patients who have completed earlier treatment phases.

02 Psychiatric Therapeutics

Advanced research in psychiatric treatment focusing on developing safer, more effective therapies for individuals with chronic mental health conditions.

  • Long-term Safety Monitoring
  • Patient Follow-up Studies
  • Treatment Efficacy Assessment

The studies aim to enhance understanding of long-term therapeutic outcomes in patients with cognitive impairment related to schizophrenia.

03 Cognitive Health Studies

Comprehensive research examining the intersection of cognitive function and mental health conditions, with a focus on therapeutic interventions.

  • Cognitive Performance Evaluation
  • Extended Treatment Benefits
  • Safety Profile Analysis

These trials represent continued efforts to improve treatment options for individuals affected by cognitive challenges associated with psychiatric conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.